Biovision Ventures - aVenture Asset Manager Research
Biovision Ventures
Operating Status: Operating
Venture Capital firm specializing in early-stage healthcare investments in the US and Europe.
Location
Luxembourg, Luxembourg Canton, LU
Biovision Ventures is a venture capital firm specializing in early-stage healthcare investments in the US and Europe. With a singular focus on life sciences and healthcare, they prioritize companies developing novel platform-based therapeutic approaches and medical software solutions. Their investment criteria emphasize innovative science, strong IP protection, and addressing unmet clinical needs.
The firm supports groundbreaking companies translating science into transformative therapies. Biovision Ventures' portfolio includes Elucid Bioimaging, which has raised $27 million. While agnostic about diseases and modalities, they seek opportunities in therapeutics and Bio-IT, demonstrating a commitment to advancing healthcare through strategic investments in cutting-edge technologies and approaches.
Biovision Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
